Statements

Find out what Breast Cancer Care is saying about the latest drug treatments, research papers and health policy issues.

If you’re working on a story and need an expert quote, call us on 0345 092 0807 (out of hours 07702 901 334).

Responding to the publication of NICE’s updated guidance for early and locally advanced breast cancer, Samia al Qadhi, Chief Executive of Breast Cancer...

Responding to the news that flight attendants are more likely to develop several forms of cancer than the average person, Addie Mitchell, Clinical Nurse...

Responding to new evidence from the Institute of Cancer Research suggesting that higher BMIs in young women reduce their risk of breast cancer, Rachel...

Responding to a new review by the Royal College of Surgeons and the Association of Breast Surgery revealing that older women are less likely to receive...

Responding to a new report revealing hundreds of women with breast cancer are being denied or rushed into surgery as policies restrict breast...

Responding to the announcement by NICE to not recommend Perjeta (pertuzumab) for routine NHS use after surgery for early HER2-positive breast cancer,...

Responding to the news that older breast cancer patients in England are less likely to survive the disease than those in Belgium, Poland, Ireland and the...

Responding to the news fish oil supplements may help alleviate the painful side effects of some breast cancer treatments, Jane Murphy, Clinical Nurse...

Responding to new research presented at ASCO 2018 suggesting that a high inflammatory diet may be connected to a higher risk of developing breast cancer...

Responding to results from the TAILORx trial revealing a greater number of women with an intermediate risk of breast cancer recurrence can avoid...